PRESS-RELEASE filed Sep 9, 2026 at 16:17 ET
CooperCompanies reported fiscal Q3 2026 non-GAAP EPS of $1.15, a 2.7% beat vs consensus of $1.12, on revenue of $1.066B (1% YoY growth, in line with $1.10B consensus). However, CooperVision revenue was flat YoY at $717M, and Q4 guidance for CVI organic growth of -2% to 0% signals continued channel inventory headwinds. The company completed its strategic review, expanded its buyback authorization to $3B, and repurchased $339M in stock, but the core contact lens business remains under pressure, making this a mixed read-through for the stock.